EGFR and non-small cell lung carcinoma: To model the efficacy of vaccination against EGFR to prevent primary NSCLC resulting from EGFR mutation, a gene-engineered murine model was established to inducibly express full-length human EGFR gene with the L858R mutation in their lungs upon doxycycline administration.